Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase
A series of novel triazoloquinolinone and imidazoquinazolinone derivatives were designed and synthesised, and their biological activities against SHP2 protein and melanoma A357 cell line were evaluated in vitro. The results show that some target compounds have moderate to excellent inhibitory activi...
Saved in:
Main Authors: | Wenjun Ye (Author), Ye Liu (Author), Qian Ren (Author), Tianhui Liao (Author), Yumei Chen (Author), Dongmei Chen (Author), Sisi Wang (Author), Lihong Yao (Author), Yihe Jia (Author), Chunshen Zhao (Author), Zhixu Zhou (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors
by: Rongshuang Luo, et al.
Published: (2021) -
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
by: Zhendong Song, et al.
Published: (2021) -
Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics
by: Jian Gao, et al.
Published: (2022) -
Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds
by: Wenjie Guo, et al.
Published: (2020) -
Discovery of TK-642 as a highly potent, selective, orally bioavailable pyrazolopyrazine-based allosteric SHP2 inhibitor
by: Kai Tang, et al.
Published: (2024)